U. Costabel (Essen, Germany), M. Judson (Charleston, United States of America)
Upper respiratory tract involvement of sarcoidosis in the Turkish population
H. Yanardag, I. Papila, M. Enoz, S. Uygun, M. Caner, T. Karayel (Istanbul, Turkey)
|  |
Changes of chest roentgenogram during a double blind randomized trial of infliximab for chronic pulmonary sarcoidosis
M. Drent, U. Costabel, R. Shipley, S. Desai, M. Judson, R. du Bois, K. H. Lo, R. Watt, R. P. Baughman (Maastricht, Netherlands; Essen, Germany; Cincinnati, Charleston, Malvern, United States Of America; London, United Kingdom)
|  |
Phenotyping sarcoidosis
A. Prasse, C. Katic, M. Germann, G. Zissel, J. Müller-Quernheim (Freiburg, Germany)
| |
Serum chitotriosidase levels in granulomatous lung disorders
B. Elena, M. Maria Antonietta, P. Anna, N. Nikolaos, L. Alice, G. Salvatore, R. Paola (Siena, Italy)
| |
Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data
M. Westhoff, P. Litterst, L. Freitag, V. Ruzsanyi, J. I. Baumbach (Hemer, Dortmund, Germany)
| |
Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
D. Colleselli, S. Oberthaler, P. Heininger, J. Loeffler-Ragg, P. Eller, C. M. Kaehler (Innsbruck, Austria)
| |
Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients
J. Müller-Quernheim, K. I. Gaede, E. Fireman, G. Zissel (Freiburg, Borstel, Germany; Tel Aviv, Israel)
| |
Lung function disturbances in 1084 sarcoidosis patients: which type of ventilatory impairment is the most common?
P. W. Boros, M. M. Martusewicz-Boros, M. Franczuk, S. Wesolowski (Warsaw, Poland)
| |